Lisa M Horowitz1, Jeffrey A Bridge2, Mary V Tipton3, Ted Abernathy4, Annabelle M Mournet3, Deborah J Snyder3, Elizabeth C Lanzillo3, Daniel Powell3, Michael Schoenbaum5, Khyati Brahmbhatt6, Maryland Pao3. 1. Office of the Clinical Director, National Institute of Mental Health, Bethesda (LM Horowitz, MV Tipton, AM Mournet, DJ Snyder, EC Lanzillo, D Powell, and M Pao), Md. Electronic address: horowitzl@mail.nih.gov. 2. The Abigail Wexner Research Institute at Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus (JA Bridge), Ohio. 3. Office of the Clinical Director, National Institute of Mental Health, Bethesda (LM Horowitz, MV Tipton, AM Mournet, DJ Snyder, EC Lanzillo, D Powell, and M Pao), Md. 4. Pediatric & Adolescent Health Partners, Richmond (T Abernathy), Va. 5. Division of Services and Intervention Research, National Institute of Mental Health (NIMH), Bethesda (M Schoenbaum), Md. 6. University of California, San Francisco, UCSF Benioff Children's Hospital, Department of Psychiatry and Behavioral Science, San Francisco (K Brahmbhatt), Calif.
Abstract
OBJECTIVE: To describe the methodological development and feasibility of real-world implementation of suicide risk screening into a pediatric primary care setting. METHODS: A suicide risk screening quality improvement project (QIP) was implemented by medical leadership from a suburban-based pediatric (ages 12-25 years) primary care practice in collaboration with a National Institute of Mental Health (NIMH) suicide prevention research team. A pilot phase to acclimate office staff to screening procedures preceded data collection. A convenience sample of 271 pediatric medical outpatients was screened for suicide risk. Patients, their parents, and medical staff reported their experiences and opinions of the screening procedures. RESULTS: Thirty-one (11.4%) patients screened positive for suicide risk, with 1 patient endorsing imminent suicide risk (3% of positive screens; 0.4% of total sample). Over half of the patients who screened positive reported a past suicide attempt. Most patients, parents, and medical staff supported the implementation of suicide risk screening procedures into standard care. A mental health clinical pathway for suicide risk screening in outpatient settings was developed to provide outpatient medical settings with guidance for screening. CONCLUSIONS: Screening for suicide risk in pediatric primary care is feasible and acceptable to patients, their families, and medical staff. A clinical pathway used as guidance for pediatric health care providers to implement screening programs can aid with efficiently detecting and managing patients who are at risk for suicide. Published by Elsevier Inc.
OBJECTIVE: To describe the methodological development and feasibility of real-world implementation of suicide risk screening into a pediatric primary care setting. METHODS: A suicide risk screening quality improvement project (QIP) was implemented by medical leadership from a suburban-based pediatric (ages 12-25 years) primary care practice in collaboration with a National Institute of Mental Health (NIMH) suicide prevention research team. A pilot phase to acclimate office staff to screening procedures preceded data collection. A convenience sample of 271 pediatric medical outpatients was screened for suicide risk. Patients, their parents, and medical staff reported their experiences and opinions of the screening procedures. RESULTS: Thirty-one (11.4%) patients screened positive for suicide risk, with 1 patient endorsing imminent suicide risk (3% of positive screens; 0.4% of total sample). Over half of the patients who screened positive reported a past suicide attempt. Most patients, parents, and medical staff supported the implementation of suicide risk screening procedures into standard care. A mental health clinical pathway for suicide risk screening in outpatient settings was developed to provide outpatient medical settings with guidance for screening. CONCLUSIONS: Screening for suicide risk in pediatric primary care is feasible and acceptable to patients, their families, and medical staff. A clinical pathway used as guidance for pediatric health care providers to implement screening programs can aid with efficiently detecting and managing patients who are at risk for suicide. Published by Elsevier Inc.
Authors: Lisa M Horowitz; Elizabeth A Wharff; Annabelle M Mournet; Abigail M Ross; Sandra McBee-Strayer; Jian-Ping He; Elizabeth C Lanzillo; Erina White; Emory Bergdoll; Daniel S Powell; Martine Solages; Kathleen R Merikangas; Maryland Pao; Jeffrey A Bridge Journal: Hosp Pediatr Date: 2020-09
Authors: Alex R Kemper; Cody A Hostutler; Kristen Beck; Cynthia A Fontanella; Jeffrey A Bridge Journal: Pediatrics Date: 2021-06-07 Impact factor: 7.124
Authors: Lisa M Horowitz; Deborah J Snyder; Edwin D Boudreaux; Jian-Ping He; Colin J Harrington; June Cai; Cynthia A Claassen; Joan E Salhany; Tram Dao; John F Chaves; David A Jobes; Kathleen R Merikangas; Jeffrey A Bridge; Maryland Pao Journal: Psychosomatics Date: 2020-04-28 Impact factor: 2.386
Authors: Kimberly Roaten; Lisa M Horowitz; Jeffrey A Bridge; Christian R R Goans; Chris McKintosh; Russell Genzel; Celeste Johnson; Carol S North Journal: J Acad Consult Liaison Psychiatry Date: 2021-03-09
Authors: Khyati Brahmbhatt; Brian P Kurtz; Khalid I Afzal; Lisa L Giles; Elizabeth D Kowal; Kyle P Johnson; Elizabeth Lanzillo; Maryland Pao; Sigita Plioplys; Lisa M Horowitz Journal: Psychosomatics Date: 2018-09-22 Impact factor: 2.386
Authors: Lynsay Ayer; Lisa M Horowitz; Lisa Colpe; Nathan J Lowry; Patrick C Ryan; Edwin Boudreaux; Virna Little; Stephen Erban; Soett Ramirez-Estrada; Michael Schoenbaum Journal: J Acad Consult Liaison Psychiatry Date: 2022-05-23